Trial Profile
A randomized, double-blind study evaluating efficacy and safety of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2019
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 04 Nov 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.